Read More Pharma Industry News EC approves AstraZeneca’s Tagrisso with chemotherapy for EGFR-mutated lung cancer AstraZeneca has received approval from the European Commission (EC) to use its cancer drug, Tagrisso (osimertinib), in combination… byPallavi MadhirajuJuly 7, 2024